Naser Ahmad Joudeh - Dec 17, 2020 Form 3 Insider Report for Medicine Man Technologies, Inc. (SHWZ)

Role
Filer
Signature
Naser Ahmad Joudeh
Stock symbol
SHWZ
Transactions as of
Dec 17, 2020
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 02:30 PM
Next filing
Jul 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SHWZ Series A Cumulative Convertible Preferred Stock Dec 17, 2020 Common stock 1.19M $1.20 Direct F1, F2, F3
holding SHWZ Series A Cumulative Convertible Preferred Stock Dec 17, 2020 Common stock 645K $1.20 Direct F1, F2, F3
holding SHWZ Series A Cumulative Convertible Preferred Stock Dec 17, 2020 Common stock 498K $1.20 Spouse F1, F2, F3
holding SHWZ Series A Cumulative Convertible Preferred Stock Dec 17, 2020 Common stock 198K $1.20 Direct F1, F2, F3
holding SHWZ Warrants (Right to Buy) Dec 17, 2020 Common stock 268K $1.20 Direct F4
holding SHWZ Warrants (Right to Buy) Dec 17, 2020 Common stock 145K $1.20 Direct F4
holding SHWZ Warrants (Right to Buy) Dec 17, 2020 Common stock 112K $1.20 Spouse F4
holding SHWZ Warrants (Right to Buy) Dec 17, 2020 Common stock 44.5K $1.20 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
F2 Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.
F3 Subject to adjustment, as described in the Certificate of Designation.
F4 The reporting person received the warrants under Asset Purchase Agreements entered into by entities partly-owned by the reporting person upon the sale of assets by such entities to the issuer on the following dates: December 17, 2020; December 18, 2020; and February 3, 2021.